title: To Study the Clinical, Biochemical and Radiological Features of Acute Pancreatitis in HIV and AIDS.
abstract: BACKGROUND
  Pancreatitis complicating HIV infection, even in the Highly Active Antiretroviral Therapy (HAART) era, remains a management challenge. We felt there is a need to discern patterns in the biochemical markers, radiological studies, co-infections, length of stay (LOS) in patients with HIV or AIDS AND pancreatitis.
  
  
  METHODS
  This is a retrospective study conducted from June, 2008 to August, 2010 on patients admitted with acute pancreatitis to our hospital. We extracted and compared the following parameters: biochemical markers, HBV markers (surface antigen, core antibody and surface antibody), HCV antibody, radiological studies, and length of stay (LOS). The Balthazar Grade score was used to assess radiological severity of disease. We stratified the cohort into comparison subsets according to CD4 count.
  
  
  RESULTS
  Ninety-four admissions met the criteria for HIV or AIDS AND pancreatitis; 67 unique patients comprised the cohort. Median age was 48 years (range, 23 to 60 years). Thirty seven (55%) were male, 30 (45%), female. Two third (n = 51) (76%) were African American. Known risk factors included a history of pancreatitis, 17 (25%); cholecystitis, 13 (19%); alcohol abuse, 25 (37%); Intravenous drug abuse, 18 (27%). Only 36 (38%) admissions were on HAART regimen. Biochemical features on admission were: WBC, 6,100/mm(3) (900 - 25,700); amylase, 152 U/L (30 - 1,344); lipase, 702.5 U/L (30 - 5,766), triglyceride, 65 mg/dL (57 - 400); glucose, 94 mg/dL (60 - 1,670); lactate, 2.3 mmol/L (1.09 - 5.49); AST, 61.5 U/L (9 - 1,950); LDH, 762 U/L (394 - 5,500); bicarbonate 19.5 mEq/L (3.3 - 82.7). Interestingly, 62% patients had normal pancreas on CT scan on admission. Of 67 individuals, hepatitis profile was available in 43, 21 (49%) were positive for HCV, 11 (26%) had markers for HBV. Four of 11 patients (36) with CD4 < 50 had evidence of persistent HBV (+core, -surface ab). Patients with CD4 < 200 have a median time for hospital course of 8 days (range 4 - 61 days) compare to 3 days in patients with CD4 > 200. P = 0.03 via t-test comparison. One patient with CD4 < 50 died due to acute pancreatitis.
  
  
  CONCLUSIONS
  Pancreatitis remains a major cause of morbidity in HIV-infected individuals. This study has provided detailed features in the HAART therapy era about the clinical, biochemical and radiological features of pancreatitis. Half of our patients were positive for HCV; additionally, 36% with CD4 < 50 had persistent HBV. As opposed to earlier studies, we did not find a female predominance. Patients with CD4 < 200 had a 2.67-fold increase length of stay. Future studies are needed for a closer look on viral cofactors which might precipitate episodes of acute pancreatitis.
authors: Department of Internal Medcine, Brookdale University Hospital and Medical Center, New York, NY, USA.
authors: Shahzad
authors: S
authors: Raza
authors: Naueen A
authors: NA
authors: Chaudhry
authors: Jordan D
authors: JD
authors: Brown
authors: Sina
authors: S
authors: Aghaie
authors: Damoun
authors: D
authors: Rezai
authors: Areej
authors: A
authors: Khan
authors: Paul De Leon
authors: Pde L
authors: Tan
authors: Barbara J
authors: BJ
authors: Berger
keywords: AIDS; HIV; Hepatitic C virus; Hepatitis B virus; Highly Active Antiretroviral Therapy (HAART); Pancreatitis
references: Lancet. 2003 Jul 5;362(9377):22-9
references: 12853195
references: AIDS. 2000 Sep 8;14(13):1879-86
references: 10997390
references: Pancreas. 2003 Mar;26(2):153-9
references: 12604913
references: Am J Med. 1995 Mar;98(3):243-8
references: 7872340
references: J Clin Gastroenterol. 1993 Oct;17(3):254-63
references: 8228089
references: Lancet. 1987 Sep 5;2(8558):570-1
references: 2887861
references: AJR Am J Roentgenol. 2004 Nov;183(5):1261-5
references: 15505289
references: J Acquir Immune Defic Syndr. 2005 Jun 1;39(2):159-66
references: 15905731
references: Mayo Clin Proc. 1992 Sep;67(9):839-45
references: 1434927
references: Am J Gastroenterol. 1997 Nov;92(11):2044-8
references: 9362189
references: Gastroenterology. 1990 Jul;99(1):263-7
references: 2160899
references: Am J Med. 1999 Jul;107(1):78-84
references: 10403356
references: Lancet. 1988 Jan 2-9;1(8575-6):65-6
references: 2891934